Lipidor AB banner
L

Lipidor AB
F:L7R

Watchlist Manager
Lipidor AB
F:L7R
Watchlist
Price: 0.0073 EUR Market Closed
Market Cap: €5.9m

Lipidor AB
Investor Relations

Lipidor AB is a drug development company. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2019-09-27. The firm is focused to develop, patent and commercialize formulation concepts and technologies based on lipids. The firm develops product concepts based on AKVANO technology, which represents a dosage form that creates a lipid layer on the skin surface for effective delivery of drugs and skin care treatment. The Company’s cooperation partners include Cerbios-Pharma, which specializes in the development and manufacturing of chemical and biological active pharmaceutical ingredients (APIs), and Aurena Laboratories AB, a manufacturer of bag-on-valve aerosol sprays for the pharmaceutical and medical device industry.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Ola Holmlund
Chief Executive Officer
No Bio Available
Mr. Olle Holmertz
Founder & Business Controller
No Bio Available
Mr. Anders Carlsson Ph.D.
Co-Founder, Senior Advisor & Chief Development Officer
No Bio Available
Dr. Bengt Herslöf Ph.D.
Co-founder & Senior Scientific Advisor
No Bio Available
Dr. Jan Holmbäck Ph.D.
Co-Founder & Chief Scientific Officer
No Bio Available
Dr. Gerhard Miksche Ph.D.
Co-Founder
No Bio Available
Ms. Charlotta Ekman
Chief Financial Officer
No Bio Available
Ms. Vibhu Rinwa
Chief Operating Officer
No Bio Available

Contacts

Address
STOCKHOLM
Danderyd
Svardvagen 13
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett